Subcutaneous Naltrexone Therapy (SNT) for Management of Addictions and for Weight Loss

Luis Martínez, M.D., MPH

President, XanoGene Clinic, San Juan, Puerto Rico; President, Regenera Global, Ponce, Puerto Rico

Naltrexone is FDA approved either as a stand-alone therapy or as combination therapy for the management of addictions and weight loss. One of the challenges with naltrexone therapies as it relates to these conditions is compliance. Subcutaneous Naltrexone Therapy (SNT) is an option for many patients who are candidates for therapy. This lecture will review the history of naltrexone implants and the evidence for their use. We will also detail how the actual procedure is performed and dosing will be discussed. Attendees will learn the fundamentals of incorporating Subcutaneous Naltrexone Therapy in their practices.